Our CDT collaborates with a variety of partners across industry, academia, the third sector and NHS. Some of the key industry partners supporting the CDT are featured here. Roche PharmaceuticalsHealthcare research and innovation benefit greatly from collaborations between academia and industry. We value the research excellence of world-class institutes such as Edinburgh and, in turn, contribute expertise, data, real-world applications, etc. to create synergy and mutual benefit.As our business is based on developing innovative healthcare solutions that benefit patients and society, we are committed to investing in future generations of talented researchers through programmes such as this CDT. AstraZenecaAstraZeneca collaborate with academic institutions and non-profit R&D partners globally to access the best science, to stimulate innovation and to deliver life-changing medicines to patients.AstraZeneca had more than 1,500 active academic collaborations during 2023. They support more than 900 early career positions in R&D globally, including graduates, placement students, sponsored PhDs, and postdoctoral researchers.Through their Open Innovation programme, AstraZeneca openly share molecules, data and challenges with academic researchers. Canon Medical Research EuropeAt Canon Medical Research Europe we are committed to a triple helix approach for our research, involving close collaboration of Academia, Industry and Healthcare professionals. We feel this is the only way to succeed in creating innovative solutions that both address current needs and can be implemented at the scale required to transform healthcare and patient journeys.By working with the University of Edinburgh in this way we can find new and deeper collaborations to help us advance our work, as well as helping to train the next generation of AI scientists. OptosOptos have been a pioneering retinal imaging company for over 30 years. Born out of a need to preserve the sight of the founder’s son, we have grown to be the technology leader in our field – with products as likely to be found in High-Street Opticians or some of the World’s leading Eye Hospitals. We are now part of the Nikon Healthcare Division, and delivering a broad range of products aligned to a mission of Saving Sight and Saving Lives.We work with our Academic partners – such as the University of Edinburgh – to ensure that this mission continues, and we keep bringing impactful technology to our customers – ultimately to benefit their patients. GSKGlaxoSmithKline (GSK), a leading biopharmaceutical company, values fostering talented researchers to drive biomedical innovation. Through collaboration with the Centre for Doctoral Training in Biomedical Innovation, GSK aims to attract and develop PhD students, offering mentorship and industry insights on cutting-edge projects. The partnership will bridge academia and industry, nurturing innovation and entrepreneurship. By training future researchers, GSK seeks to keep its R&D at the forefront of science while advancing medical knowledge and developing new treatments globally. NECNEC Labs is part of NEC’s Life Science Innovation Hub, designed to orchestrate the functions of NEC’s AI Drug Development Division within Europe. Our computational pipelines combine bioinformatics and machine learning approaches for the development of new therapies across a wide range of clinical needs.A key goal for NEC Labs is social implementation and we are particularly excited by the way that the CDT in Biomedical Innovation has been designed to focus on innovative research yet at the same time to bring emphasis to how innovations can translate into real-world use. Scottish Informatics and Computer Science Alliance (SICSA)SICSA’s remit is to foster collaboration across research, knowledge exchange, research student training and computer science education across 14 Scottish universities. We also act as the gateway to Scottish Computing Science for international partners, industry, government and the third sector, speaking as the voice of Scottish Computing Science. The Biomedical Innovation CDT is a priority means of fulfilling our strategic aims. FUJIFILM Diosynth BiotechnologiesFUJIFILM Diosynth Biotechnologies is a leading contract development and manufacturing organization (CDMO) providing process development and manufacturing of biologics. Data Driven Decision Making for Bioprocessing is increasingly adopting Machine Learning/ AI via the application of advanced digital technologies.We look forward to coordinating with the Centre for Doctoral Training In Biomedical Innovation through designing new research questions and supporting the development of innovative outcomes and supporting talent development in the ever increasingly important topic of AI and Machine Learning in the biomedical sector. UCB Biopharma UKUCB is a global biopharmaceutical company focused on transforming the lives of people with neurological and immunological conditions. In the UK & Ireland, it reinvests ~25% of revenue into research through its discovery hub for immunology therapies, employing 10% of its global workforce, mostly scientists dedicated to R&D.In 2022, UCB invested £18.5m in early-stage collaborations with 119 UK partners across 253 projects, contributing ~£250m to UK research since 2004. It maintains strong ties with the University of Edinburgh and supports four active PhD partnerships using novel technologies like machine learning and AI to enhance research impact.Currently, UCB supports 20 PhD studentships at nine universities (£1m invested), having backed 200 PhDs since 2004, alongside apprenticeships, graduate placements, and staff training. In 2022, it also funded 22 Investigator Initiated Studies and 22 External Research Collaborations worth £3.6m. UCB remains driven by science and inspired by patients. This article was published on 2025-09-18